Food supplements – are they safe
Keywords:
hepatotoxicity, nutritional supplement, treatmentAbstract
Recently, it has become more and more common in practice to prescribe and use dietary supplements, often in combination with medications, for various chronic neurological disorders. Evidence of herbal and dietary supplement-induced liver injury (HILI) as part of the drug-induced liver injury (DILI) group are increasing in the literature. Such liver damage can also be caused by ingredients considered useful and harmless, such as green tea or turmeric. The mechanism is probably a form of idiosyncrasy. The clinical picture ranges from asymptomatic elevated liver enzymes, to severe liver failure and encephalopathy. It usually manifests itself with non-specific symptoms such as fatigue, anorexia, nausea or cholestasis. Usually, stopping the causative ingredient is sufficient for treatment, in more severe cases, treatment with prednisone or n-acetyl cysteine is required. In 2% of the patients, a liver transplant is required.
In conclusion, herbal products and dietary supplements are potentially beneficial in combination therapy, but they are not harmless. In comorbidities and in combinations, they can lead to hepatotoxicity and drug interactions. Further studies are needed, as well as extensive training of doctors, patients and pharmacists, as well as education and informing health authorities and the public about the possible benefits and risks of using dietary supplements and herbal products for treatment in practice.
References
Ballotin, V., Bigarella, L.G., Brandão, A.B.M., Balbinot, R.A., Balbinot, S.S., Soldera, J. Herb-induced liver injury: Systematic review and meta-analysis. World J Clin Cases. 2021, 16, 9, 5490-5513.
Björnsson, E.S., Stephens, C., Atallah, E., Robles-Diaz, M., Alvarez- Alvarez, I., Gerbes, A., Weber, S., Stirnimann, G., Kullak- Ublick, G., Cortez-Pinto, H. et al. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry. Liver Int. 2023, 43, 115-126.
Chirapongsathorn, S., Chirapongsathorn, S., Sukeepaisarnjaroen, W., Sukeepaisarnjaroen, W., Treeprasertsuk, S., Treeprasertsuk, S., Chaiteerakij, R.,Chaiteerakij, R., Surawongsin, P., Surawongsin, P., et al. Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry. J. Clin. Transl. Hepatol. 2023, 11, 88.
D'Egidio, F., Lombardozzi, G., Kacem Ben Haj, M'Barek H.E., Mastroiacovo, G., Alfonsetti, M., Cimini, A. The Influence of Dietary Supplementations on Neuropathic Pain. Life (Basel). 2022, 27, 12, 1125.
Huang, Y.S., Chang, T.T., Peng, C.Y., Lo, G.H., Hsu, C.W., Hu, C.T., Huang, Y.H. Herbal and dietary supplement-induced liver injury in Taiwan: Comparison with conventional drug-induced liver injury. Hepatol. Int. 2021, 15, 1456-1465.
Frediani, J.K., Lal, A.A., Kim, E., Leslie, S.L., Boorman, D.W., Singh, V. The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: A systematic review. Pain Pract. 2024, 24, 186-210.
Fontana, R.J., Liou, I., Reuben, A., Suzuki, A., Fiel, M.I., Lee, W., Navarro, V. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology 2023, 77, 1036-1065.
Lin, JK.S., Tujios, S.R. Hidden Dangers: Herbal and Dietary Supplement Induced Hepatotoxicity. Livers. 2023, 3, 618-636.
Patel-Rodrigues, Palak A. et al. Herbal- and Dietary-Supplement-Induced Liver Injury: A Review of the Recent Literature. Livers, 2024.
Ronis, M.J., Pedersen, K.B., Watt, J. Adverse Effects of Nutraceuticals and Dietary Supplements. Annu Rev Pharmacol Toxicol. 2018, 6, 583-601.
Strocka, J., Religioni, U., Plagens-Rotman, K., Drab, A., Merks, P., Kaźmierczak, J., Blicharska, E., Pinkas, J. Knowledge and Practices Regarding Dietary Supplements Among Healthcare Professionals in Poland. Nutrients. 2024, 29, 3691.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Desislava Bogdanova

This work is licensed under a Creative Commons Attribution 4.0 International License.